What hides behind the MASC: clinical response and acquired resistance to entrectinib afterETV6-NTRK3identification in a mammary analogue secretory carcinoma (MASC)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What hides behind the MASC: clinical response and acquired resistance to entrectinib afterETV6-NTRK3identification in a mammary analogue secretory carcinoma (MASC)
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue 5, Pages 920-926
Publisher
Oxford University Press (OUP)
Online
2016-02-17
DOI
10.1093/annonc/mdw042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mammary Analogue Secretory Carcinoma of Salivary Glands
- (2016) Alena Skálová et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mammary Analogue Secretory Carcinoma of Salivary Glands
- (2015) Yohei Ito et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
- (2015) A. Drilon et al. CLINICAL CANCER RESEARCH
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2015) R. C. Doebele et al. Cancer Discovery
- Next-Generation Sequencing Reveals a Novel NSCLC ALK F1174V Mutation and Confirms ALK G1202R Mutation Confers High-Level Resistance to Alectinib (CH5424802/RO5424802) in ALK-Rearranged NSCLC Patients Who Progressed on Crizotinib
- (2014) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- Most Nonparotid “Acinic Cell Carcinomas” Represent Mammary Analog Secretory Carcinomas
- (2013) Justin A. Bishop et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells
- (2013) Mikko Taipale et al. NATURE BIOTECHNOLOGY
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Case 16-2013: A Girl with Irritability, Hypersomnia, and Somatic Symptoms
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
- (2012) R. Katayama et al. Science Translational Medicine
- Mammary Analog Secretory Carcinoma of Salivary Gland Origin With the ETV6 Gene Rearrangement by FISH
- (2011) Ashton Connor et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started